237690.KQ KOE
ST Pharm Co.,Ltd.
1W: +2.2%
1M: -9.4%
3M: -29.1%
YTD: -38.8%
1Y: +4.5%
3Y: +29.4%
5Y: -15.2%
₩93,300.00 ($69.47)
-2300.00 (-2.41%)
Weekly Expected Move ±6.1%
₩81872
₩87586
₩93300
₩99014
₩104728
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$17.5B
-84.0% ▼
Capital Expenditures
$47.1B
+43.4% ▲
5Y CAGR: +22.0%
Free Cash Flow
-$29.6B
-212.7% ▼
Dividends Paid
$10.1B
-7.1% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$32.9B
-346.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $3.3B | $18.0B | $19.6B | $32.5B | $55.0B |
| Depreciation & Amort. | $14.4B | $17.6B | $23.0B | $25.6B | $29.9B |
| Stock-Based Comp. | $2.1B | $5.0B | $5.3B | $3.2B | $0 |
| Change in Working Capital | -$21.4B | -$40.8B | -$64.8B | $36.7B | -$76.9B |
| Other Non-Cash Items | $8.9B | $7.2B | $18.2B | $11.5B | $9.6B |
| Operating Cash Flow | $7.3B | $7.0B | $1.3B | $109.5B | $17.5B |
| — Investing Activities — | |||||
| Capital Expenditures | -$51.9B | -$60.7B | -$43.2B | -$82.8B | -$47.3B |
| Acquisitions (Net) | $1.8B | $4M | $0 | $0 | $52M |
| Investment Purchases | -$317.6B | -$250.8B | -$151.1B | -$399.5B | -$199.2B |
| Investment Sales | $360.1B | $304.8B | $110.7B | $391.4B | $217.7B |
| Other Investing | -$47M | -$504M | $1.2B | $4.3B | -$1.7B |
| Investing Cash Flow | -$7.7B | -$7.1B | -$82.4B | -$86.5B | -$30.4B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1.0B | $21.5B | $92.5B | $789M | -$7.3B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$9.4B | -$9.4B | -$9.4B | -$10.1B |
| Other Financing | $202M | -$358M | -$1.7B | -$2.3B | -$2.1B |
| Financing Cash Flow | -$816M | $11.7B | $81.4B | -$11.0B | -$19.5B |
| Net Change in Cash | $578M | $11.0B | -$104M | $13.3B | -$32.9B |
| Cash End of Period | $39.2B | $50.2B | $50.1B | $63.4B | $30.5B |
| Free Cash Flow | -$44.3B | -$53.2B | -$42.1B | $26.2B | -$29.6B |